Medical Devices

A new T-cell therapy, RPTR-1-201, enters clinical trials, offering hope for hard-to-treat solid tumors by targeting a shared, multi-cancer marker.

Winning top awards, China's Fosun Health unveils a bold strategy to become the premier gateway for Southeast Asian patients seeking advanced medical care.

As Materialise preps its Q1 2026 report, all eyes are on its booming medical unit to see if it can offset persistent industrial market weakness.

Breakthrough trial data shows a new device can keep donor hearts viable for longer, potentially expanding the organ pool and saving thousands on waitlists.

As its leaders vie for a top entrepreneurial award, a look at how GenScript quietly became an indispensable engine for global scientific breakthroughs.

A new AI-powered skin patch test for psoriasis just got a major US approval, promising to end costly trial-and-error treatments for millions of patients.

A breakthrough review validates harnessing neutrophils, the immune system's foot soldiers, for cancer, with a new therapy now heading to human trials.

New TempLock™ tech in the SherpaPak® system aims to keep donor hearts stable longer, potentially expanding the reach of life-saving transplants.

A novel, minimally invasive nerve ablation technology shows long-term promise for relieving severe pancreatic cancer pain, a major unmet medical need.

With over 47,000 members, Astiva Health's culturally tailored Medicare plans are outpacing rivals. Now, it's pivoting toward sustainable profit.

A novel gene therapy using precision-guided vectors could offer a one-time treatment for wet AMD, a leading cause of blindness, freeing patients from injections.

With a fresh CAD $1M in funding, Grey Matters is set to enter the booming U.S. neuroimaging market, targeting early Alzheimer's detection.

The Pacific Northwest's largest dermatology practice is opening a new clinic in Issaquah, bringing comprehensive skin care to a competitive, growing market.

For the 5th straight year, WA's life sciences outpace job growth. See how AI leadership and strategic investment fuel its $43.4B economic impact.

As Varex prepares its Q2 report, investors watch to see if booming industrial sales and medical innovations can sustain its impressive market momentum.

By achieving rigorous ONC certification, surgeon-developed 4D EMR is enhancing data security and interoperability for the unique needs of plastic surgery.

With rising cancer rates, Utepreva's innovative sampler promises more accurate and comfortable tissue collection, potentially transforming early diagnosis.

The arrival of South Africa's first generic hormonal IUD aims to tackle high costs and low uptake of long-acting contraception in a nation of high unplanned pregnancies.

Hundreds of lupus advocates descended on Washington, demanding policy reform and research funding, and their persistent efforts are already yielding major results.

EXALTA Group's new ISO 17025 accreditation for its in-house lab aims to slash development time, reflecting a broader industry push for integrated partners.